Allergan Launches 2nd Suit Over Combigan Patents

Law360, New York (June 08, 2009, 12:00 AM ET) -- Allergan Inc. has accused Hi-Tech Pharmacal Co. Inc. of infringing two patents for Combigan, marking the second time in less than two months the drug manufacturer has moved to block a generics maker from selling its own version of the glaucoma treatment.

The complaint, filed Friday in the U.S. District Court for the Eastern District of Texas, takes aim at an abbreviated new drug application that Hi-Tech submitted to the U.S. Food and Drug Administration in a bid to market a generic copy of Combigan before...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required